buspirone has been researched along with Benedict Syndrome in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Khatib, MF | 1 |
| Kiwan, RA | 1 |
| Jamaleddine, GW | 1 |
1 other study available for buspirone and Benedict Syndrome
| Article | Year |
|---|---|
Buspirone treatment for apneustic breathing in brain stem infarct.
Topics: Apnea; Brain Stem Infarctions; Buspirone; Humans; Male; Middle Aged; Serotonin Receptor Agonists | 2003 |